Supervisor Elham AbolFateh
Editor in Chief Mohamed Wadie

US to Distribute 144,000 Monkeypox Vaccine Doses


Sat 09 Jul 2022 | 12:03 AM
Rana Atef

The US announced on Thursday that the authorities will distribute more than 144,000 doses of Jynneos vaccine that showed efficiency against Monkeypox amid the recent spike of the virus.

The Department of Health and Human Services (HHS) expressed in a statement that the shipping of the doses will begin next week.

The concerned health authorities distributed more than 41,000 doses of the vaccine since the virus emerged nationwide in May.

The vaccines will be sent first to the states that see high emergence of the virus and cases that could be at risk.

The Director of the Strategic National Stockpile Steve Adams said that authorities are “using every tool” they have to protect the cases that could be at risk.

Adams added in an official statement: “These are critical components of our overall effort to combat this virus, and we will continue to coordinate closely with states and jurisdictional partners to make sure they have the vaccines, testing, and treatments needed to respond to the current outbreak."

Jynneos vaccine is a two-dose one, and it was approved by the FDA for adults ages 18 and older who are at high risk of exposure to smallpox, and it showed efficiency against Monkeypox.

The US Centers for Disease Control and Prevention announced last week that the total confirmed cases of Monkeypox reached 306 infections.

The confirmed cases were reported across 27 states and Washington, D.C., in addition, the major outbreaks of the virus are in California, Illinois and New York.

No reported deaths in the US until now, and the majority of patients recovered in two to four weeks.